Atrium Therapeutics, Inc. · NASDAQ:RNA
Hoyos Rocio Martin had 8,320 Atrium Therapeutics, Inc. shares withheld for tax (Form 4)
Traded Sep 18, 2026 · Filed Sep 22, 2026
On Sep 18, 2026, Hoyos Rocio Martin (Chief Strategy Officer) had 8,320 Atrium Therapeutics, Inc. shares withheld for tax at US$8.95 for US$74,464, leaving 38,340 shares. Filed Sep 22, 2026 (Form 4).
- Withheld for tax
- 8,320 shares
- Price
- US$8.95
- Value
- US$74,464
- Holding after
- 38,340 shares
- Trading plan
- No
- Role
- Chief Strategy Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 18, 2026 | Common Stock | Shares withheld for tax | 8,320 | US$8.95 | 38,340 | Direct |
Source
Related
- Atrium Therapeutics, Inc.
- Hoyos Rocio Martin
- Atrium Therapeutics, Inc. shareholders
- Form 4 · Hoyos Rocio Martin · Apr 22, 2026
- Form 4 · Younis Husam · Sep 22, 2026
- Form 4 · Hughes Steven George · Sep 22, 2026
- Form 4 · Flanagan W. Michael · Sep 22, 2026
- Form 4 · Boyce Sarah · Sep 22, 2026
- Form 4 · Kenney Stephanie · Sep 22, 2026